INVESTOR ALERT: Investigation Into Tokai Pharmaceuticals IPO Announced by Holzer & Holzer LLC

Holzer & Holzer is investigating whether Tokai Pharmaceuticals, Inc. (“Tokai” or the “Company”) (NASDAQ: TKAI) issued false and misleading statements to investors in connection with its September 18, 2014 initial public offering (the “IPO”).

If you purchased Tokai common stock before March 17, 2015 and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at [e-mail] or via toll-free telephone at [phone], to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161024006382/en/

Holzer & Holzer, LLCCorey D. Holzer, Esq., 888-508-6832 (toll-free)[e-mail]